U.S. Markets
Viatris (VTRS) agrees to acquire Pacira Biosciences (PCRX) for USD 1.65bln equity value, USD 36.5/shr
StockNow breaking-news AI analysis
Viatris agreed to acquire Pacira Biosciences for a stated USD 1.65 billion equity value; available evidence does not provide further terms.
Related stocks
2 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
